Roth Capital Starts Somaxon Pharma (SOMX) at Buy, $5 Price Target
Tweet Send to a Friend
An analyst at Roth Capital initiated coverage on Somaxon Pharma (NASDAQ: SOMX) with a Buy rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE